Out-patient detoxification in chronic migraine: Comparison of strategies

Cephalalgia

Volumn 23, Issue 10, 2003, Pages 982-993

  Krymchantowski, A V ^a,b   Moreira, P F ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Headache Center of Rio   (Brazil)

Author keywords

Chronic migraine; Overuse; Symptomatic medications; Withdrawal

Indexed keywords

NARATRIPTAN; OPIATE DERIVATIVE; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG ABUSE; DRUG DETOXIFICATION; FEMALE; HUMAN; INCIDENCE; MALE; MIGRAINE; OUTPATIENT; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REBOUND; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHI-SQUARE DISTRIBUTION; FEMALE; HEADACHE DISORDERS; HUMANS; INDOLES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PIPERIDINES; PREDNISONE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUBSTANCE WITHDRAWAL SYNDROME; TRYPTAMINES;

EID: 0347589714     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00648.x     Document Type: Article

References (37)

1. Mathew NT. Chronic daily headache: clinical features and natural history. In: Nappi G, editor. Headache and depression: serotonin pathways as a common clue. New York: Raven Press, 1991:49-58.
2. Krymchantowski AV, Moreira PF. Clinical presentation of transformed migraine: possible differences among male and female patients. Cephalalgia 2001; 21:558-66.
3. Castillo J, Munóz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-6.
4. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001; 21:980-6.
5. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27:102-6.
6. Mathew NT. Drug induced headache. Neurol Clin 1990; 4:903-12.
7. Rapoport AM. Analgesic rebound headache. Headache 1988; 28:662-5.
8. Rapoport AM, Weeks RE, Sheftell FD, Baskin SM, Verdi J. Analgesic rebound headache: theoretical and practical implications. Cephalalgia 1985; 5:448-9.
9. Srikiatkhachorn A, Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 1997; 37:277-80.
10. Katsarava Z, Fritsche G, Muessing M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57:1694-8.
11. Diener HC, Dahlof CGH. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 1999:871-8.
12. Silberstein SD, Lipton RB. Chronic daily headache. In: Goadsby, PJ, Silberstein SD, editor. Headache. Boston: Butterworth-Heinemann, 1997:201-25.
13. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of drug-induced daily headache. Cephalalgia 2000; 20:107-13.
14. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36:995-7.
15. Silberstein SD, Lipton RB. Chronic daily headache, including transformed migraine, chronic tension-type headache, and medication overuse. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff's Headache and Other Head Pain, 7th edn. Oxford: Oxford University Press, 2001:247-82.
16. Mathew NT. Amelioration of ergotamine withdrawal with naproxen. Headache 1987; 27:130-3.
17. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337:1442-3.
18. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990; 30:334-9.
19. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during the withdrawal from drug-induced headache. Headache 1991; 31:205-9.
20. Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M. Analgetika-Induzierter Dauerkopfchmerz. Dtsch Med Wschr 1984; 109:369-73.
21. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34:1-7.
22. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised criteria. Neurology 1996; 47:871-5.
23. Warner JS. The outcome of treating patients with suspected rebound headache. Headache 2001; 41:85-92.
24. Diener H-C, Gerber WD, Geiselhart S, Dichgans J. Short and long-term effects of withdrawal therapy in drug induced-headache. In: Diener H-C, Wilkinson M, editors. Drug-Induced Headache. Berlin: Springer, 1988:133-42.
25. Schimmer. BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman LS, Gilman A, editors. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:1459-85.
26. Sullivan JN. Saturday conference: steroid withdrawal syndromes. South Med J 1982; 75:726-33.
27. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326:1473-9.
28. Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, Wesseley P. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996; 16:481-5.
29. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber S, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989; 236:9-14.
30. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33:335-41.
31. Sheftell F, Rapoport A, Coddon D. Naratriptan in the prophylaxis of transformed migraine. Headache 1999; 39:506-10.
32. Pascual J. Worsening of transformed migraine with naratriptan as prophylactic treatment. Headache 2000; 40:610-1.
33. Drucker P, Tepper S. Daily sumatriptan for detoxification from rebound. Headache 1998; 38:687-90.
34. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999; 33:61-72.
35. Diener HC, Pfaffenrath V, Soyka D, Gerber W. Therapie des medikamenteninduzierten Kopfschmerzes. Munch Med Wschr 1992; 134:159-62.
36. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19:44-9.
37. Diener HC, Mathew NT. Drug-induced headache. In: Diener HC, editor. Drug Treatment of Migraine and Other Headaches. Monogr Clin Neurosci. Basel: Karger, 2000:347-56.